With interest we read the article by Fayssoil et al. about cardiac involvement classification and therapy in patients with Duchenne muscular dystrophy (DMD) [1]. We agree with the authors that search for cardiac involvement and cardiac therapy are important in the care of patients with DMD, however we want to add some comments and suggestions.Regarding symptoms, it is mentioned that "classical" symptoms of heart failure like exertional dyspnea or symptoms of arrhythmias like palpitations may be absent in DMD because of the limited mobility. Thus, instrumental investigations to assess the cardiac function are important. The authors recommend electrocardiogram, echocardiography and cardiac magnetic resonance imaging. However, the armamentarium of the cardiologists to detect cardiac dysfunction is larger. First, we recommend measurement of the serum levels of brain natriuretic peptide (BNP) which is a robust indicator for cardiac dysfunction, useful for diagnostic purposes and for control of therapeutic effects, as recommended by current heart failure guidelines [2]. Secondly, we suggest that in patients with suspected arrhythmia 24-Holter monitoring or, if the arrhythmias occur only rarely, implantable loop recorders (ILRs) should be considered. ILRs are small devices, implanted or injected subcutaneously in the left side of the chest under local anaesthesia. They continuously record and delete a